Table 4 Associations between health care costs and the use of antimigraine medications
From: Antimigraine medication use and associated health care costs in employed patients
Independent variables | Estimated coefficient (SE) | ||
|---|---|---|---|
Dependent variable: log (total all-cause health care costs) | Dependent variable: log (all-cause medical costs) | Dependent variable: log (total migraine-related costs) | |
Antimigraine medication use (yes vs. no) | −0.30 (0.12)** | −0.55 (0.17)*** | 0.62 (0.18)*** |
Diagnosis of migraine (yes vs. no) | −0.30 (0.10)** | −0.37 (0.14)** | 1.17 (0.15)*** |
Age (years) | −0.01 (0.28)* | −0.02 (0.01)** | 0.02 (0.01)** |
Gender (female vs. male) | 0.21 (0.18) | 0.17 (0.23) | −0.15 (0.25) |
CGI | 0.05 (0.02)* | 0.05 (0.03) | 0.05 (0.03) |
RI | 0.08 (0.01)*** | 0.08 (0.01)*** | 0.01 (0.01) |
Comorbid depression (yes vs. no) | 0.15 (0.10) | 0.19 (0.13) | 0.04 (0.14) |